Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Background Recent studies have discovered that α‐globin is expressed in blood vessel walls where it plays a role in regulating vascular tone. We tested the hypothesis that blood pressure (BP) might differ between normal individuals and those with α + thalassemia, in whom the production of α‐globin is reduced. Methods and Results The study was conducted in Nairobi, Kenya, among 938 adolescents aged 11 to 17 years. Twenty‐four‐hour ambulatory BP monitoring and arterial stiffness measurements were performed using an arteriograph device. We genotyped for α + thalassemia by polymerase chain reaction. Complete data for analysis were available for 623 subjects; 223 (36%) were heterozygous (−α/αα) and 47 (8%) were homozygous (−α/−α) for α + thalassemia whereas the remaining 353 (55%) were normal (αα/αα). Mean 24‐hour systolic BP ± SD was 118±12 mm Hg in αα/αα, 117±11 mm Hg in −α/αα, and 118±11 mm Hg in −α/−α subjects, respectively. Mean 24‐hour diastolic BP ± SD in these groups was 64±8, 63±7, and 65±8 mm Hg, respectively. Mean pulse wave velocity ( PWV )± SD was 7±0.8, 7±0.8, and 7±0.7 ms −1 , respectively. No differences were observed in PWV and any of the 24‐hour ambulatory BP monitoring‐ derived measures between those with and without α + thalassemia. Conclusions These data suggest that the presence of α + thalassemia does not affect BP and/or arterial stiffness in Kenyan adolescents.

Original publication

DOI

10.1161/jaha.117.005613

Type

Journal article

Journal

Journal of the American Heart Association

Publisher

Ovid Technologies (Wolters Kluwer Health)

Publication Date

05/04/2017

Volume

6